Market Overview

Citi Projects 16% Upside For Becton Dickinson In Upgrade

Share:
Citi Projects 16% Upside For Becton Dickinson In Upgrade

Medical supplier Becton Dickinson and Co (NYSE: BDX) is likely to outperform its own expectations, as well as the Street's, according to Citi.

The Analyst

Analyst Amit Hazan upgraded Becton Dickinson from Neutral to Buy and increased the price target from $237 to $251, suggesting 16-percent upside.

The Thesis

A strong setup for upside to the 2018 guidance and Street estimates appears to be in place, starting with the fiscal second quarter, mainly due to the Becton Dickinson side of the business, Hazan said in a Tuesday note. (See the analyst's track record here.) 

The company recently completed its acquisition of C.R. Bard; the combined company has annualized revenues of $16 billion.

Bard's growth is a key uncertainty, Hazan said. 

Citi's new drug-coated balloon, or CDB, survey indicated that market growth coupled with new indications can help maintain DCBs as at least one important Bard growth driver.

The Price Action

Becton Dickinson shares have gained over 18 percent over the past year through Monday.

At last check Tuesday, the shares were rallying 2.73 percent to $223.33. 

Related Links:

Jim Cramer Shares His Thoughts On Hain Celestial, Becton Dickinson And Carnival Corp.

The Week Ahead In Biotech: PDUFA Dates, IPOs And More

Latest Ratings for BDX

DateFirmActionFromTo
Jan 2020DowngradesOverweightEqual-Weight
Dec 2019MaintainsOverweight
Dec 2019MaintainsEqual-Weight

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: Amit Hazan CitiAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (BDX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
LLMorgan StanleyDowngrades5.0
MGPICraig-HallumDowngrades
LLEXCapital OneDowngrades
GILDGuggenheim SecuritiesDowngrades
VERUH.C. WainwrightReinstates6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com